PERIPHERAL T-CELL LYMPHOMA
Clinical trials for PERIPHERAL T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for PERIPHERAL T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat lymphoma: experimental drug BR101801 enters phase 2
Disease control Not yet recruitingThis study tests an experimental drug called BR101801 in 44 people with a rare type of blood cancer (peripheral T-cell lymphoma) that has returned or not responded to standard treatments. The main goal is to see how many patients have their tumors shrink or disappear. Participant…
Matched conditions: PERIPHERAL T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 26, 2026 04:32 UTC
-
New combo therapy offers hope for rare blood cancer
Disease control Not yet recruitingThis study tests a combination of three drugs (tazemetostat, linperlisib, and golidocitinib) in people with a type of blood cancer called peripheral T-cell lymphoma that has come back or not responded to treatment. The goal is to see if the combination can shrink tumors and contr…
Matched conditions: PERIPHERAL T-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 22, 2026 14:03 UTC